nodes	percent_of_prediction	percent_of_DWPC	metapath
Terbutaline—ADRB2—prostate cancer	0.737	1	CbGaD
Terbutaline—Bambuterol—ADRB2—prostate cancer	0.00132	0.156	CrCbGaD
Terbutaline—Orciprenaline—ADRB2—prostate cancer	0.00124	0.146	CrCbGaD
Terbutaline—Pirbuterol—ADRB2—prostate cancer	0.000998	0.118	CrCbGaD
Terbutaline—Rash—Estrone—prostate cancer	0.000823	0.00395	CcSEcCtD
Terbutaline—Dermatitis—Estrone—prostate cancer	0.000822	0.00395	CcSEcCtD
Terbutaline—Headache—Estrone—prostate cancer	0.000818	0.00393	CcSEcCtD
Terbutaline—Asthenia—Estradiol valerate/Dienogest—prostate cancer	0.000817	0.00392	CcSEcCtD
Terbutaline—Nausea—Estramustine—prostate cancer	0.000811	0.0039	CcSEcCtD
Terbutaline—Dizziness—Nilutamide—prostate cancer	0.000802	0.00385	CcSEcCtD
Terbutaline—Dizziness—Flutamide—prostate cancer	0.000798	0.00383	CcSEcCtD
Terbutaline—Insomnia—Bicalutamide—prostate cancer	0.000791	0.0038	CcSEcCtD
Terbutaline—Paraesthesia—Bicalutamide—prostate cancer	0.000786	0.00377	CcSEcCtD
Terbutaline—Dyspnoea—Bicalutamide—prostate cancer	0.00078	0.00375	CcSEcCtD
Terbutaline—Somnolence—Bicalutamide—prostate cancer	0.000778	0.00374	CcSEcCtD
Terbutaline—Asthenia—Degarelix—prostate cancer	0.000777	0.00373	CcSEcCtD
Terbutaline—Nausea—Estrone—prostate cancer	0.000775	0.00372	CcSEcCtD
Terbutaline—Vomiting—Nilutamide—prostate cancer	0.000771	0.0037	CcSEcCtD
Terbutaline—Anxiety—Ethinyl Estradiol—prostate cancer	0.000769	0.00369	CcSEcCtD
Terbutaline—Vomiting—Flutamide—prostate cancer	0.000767	0.00369	CcSEcCtD
Terbutaline—Rash—Nilutamide—prostate cancer	0.000764	0.00367	CcSEcCtD
Terbutaline—Dermatitis—Nilutamide—prostate cancer	0.000764	0.00367	CcSEcCtD
Terbutaline—Rash—Flutamide—prostate cancer	0.000761	0.00365	CcSEcCtD
Terbutaline—Dermatitis—Flutamide—prostate cancer	0.00076	0.00365	CcSEcCtD
Terbutaline—Headache—Nilutamide—prostate cancer	0.000759	0.00365	CcSEcCtD
Terbutaline—Headache—Flutamide—prostate cancer	0.000756	0.00363	CcSEcCtD
Terbutaline—Dizziness—Estradiol valerate/Dienogest—prostate cancer	0.000753	0.00362	CcSEcCtD
Terbutaline—Tension—Goserelin—prostate cancer	0.000732	0.00352	CcSEcCtD
Terbutaline—Asthenia—Cabazitaxel—prostate cancer	0.000732	0.00352	CcSEcCtD
Terbutaline—Tension—Conjugated Estrogens—prostate cancer	0.000725	0.00348	CcSEcCtD
Terbutaline—Nervousness—Goserelin—prostate cancer	0.000724	0.00348	CcSEcCtD
Terbutaline—Vomiting—Estradiol valerate/Dienogest—prostate cancer	0.000724	0.00348	CcSEcCtD
Terbutaline—Nausea—Nilutamide—prostate cancer	0.00072	0.00346	CcSEcCtD
Terbutaline—Injection site pain—Epirubicin—prostate cancer	0.00072	0.00346	CcSEcCtD
Terbutaline—Rash—Estradiol valerate/Dienogest—prostate cancer	0.000718	0.00345	CcSEcCtD
Terbutaline—Nervousness—Conjugated Estrogens—prostate cancer	0.000718	0.00345	CcSEcCtD
Terbutaline—Dermatitis—Estradiol valerate/Dienogest—prostate cancer	0.000717	0.00345	CcSEcCtD
Terbutaline—Muscle spasms—Goserelin—prostate cancer	0.000717	0.00344	CcSEcCtD
Terbutaline—Nausea—Flutamide—prostate cancer	0.000717	0.00344	CcSEcCtD
Terbutaline—Dizziness—Degarelix—prostate cancer	0.000716	0.00344	CcSEcCtD
Terbutaline—Headache—Estradiol valerate/Dienogest—prostate cancer	0.000713	0.00343	CcSEcCtD
Terbutaline—Muscle spasms—Conjugated Estrogens—prostate cancer	0.00071	0.00341	CcSEcCtD
Terbutaline—Drowsiness—Mitoxantrone—prostate cancer	0.000705	0.00339	CcSEcCtD
Terbutaline—Vomiting—Degarelix—prostate cancer	0.000688	0.00331	CcSEcCtD
Terbutaline—Cramp muscle—Etoposide—prostate cancer	0.000685	0.00329	CcSEcCtD
Terbutaline—Rash—Degarelix—prostate cancer	0.000683	0.00328	CcSEcCtD
Terbutaline—Dermatitis—Degarelix—prostate cancer	0.000682	0.00328	CcSEcCtD
Terbutaline—Headache—Degarelix—prostate cancer	0.000678	0.00326	CcSEcCtD
Terbutaline—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.000677	0.00325	CcSEcCtD
Terbutaline—Sweating—Mitoxantrone—prostate cancer	0.000676	0.00325	CcSEcCtD
Terbutaline—Dizziness—Cabazitaxel—prostate cancer	0.000675	0.00324	CcSEcCtD
Terbutaline—Injection site pain—Doxorubicin—prostate cancer	0.000666	0.0032	CcSEcCtD
Terbutaline—Fenoterol—ADRB2—prostate cancer	0.000666	0.0787	CrCbGaD
Terbutaline—Palpitations—Goserelin—prostate cancer	0.000659	0.00317	CcSEcCtD
Terbutaline—Palpitations—Conjugated Estrogens—prostate cancer	0.000653	0.00314	CcSEcCtD
Terbutaline—Ventricular extrasystoles—Epirubicin—prostate cancer	0.000651	0.00312	CcSEcCtD
Terbutaline—Clenbuterol—ADRB2—prostate cancer	0.00065	0.0769	CrCbGaD
Terbutaline—Vomiting—Cabazitaxel—prostate cancer	0.000649	0.00311	CcSEcCtD
Terbutaline—Nausea—Degarelix—prostate cancer	0.000643	0.00309	CcSEcCtD
Terbutaline—Bupranolol—ADRB2—prostate cancer	0.000643	0.076	CrCbGaD
Terbutaline—Headache—Cabazitaxel—prostate cancer	0.000639	0.00307	CcSEcCtD
Terbutaline—Chest pain—Goserelin—prostate cancer	0.000635	0.00305	CcSEcCtD
Terbutaline—Anxiety—Goserelin—prostate cancer	0.000633	0.00304	CcSEcCtD
Terbutaline—Flushing—Estradiol—prostate cancer	0.00063	0.00303	CcSEcCtD
Terbutaline—Chest pain—Conjugated Estrogens—prostate cancer	0.000629	0.00302	CcSEcCtD
Terbutaline—Asthenia—Bicalutamide—prostate cancer	0.000628	0.00302	CcSEcCtD
Terbutaline—Anxiety—Conjugated Estrogens—prostate cancer	0.000627	0.00301	CcSEcCtD
Terbutaline—Dry mouth—Goserelin—prostate cancer	0.000621	0.00298	CcSEcCtD
Terbutaline—Nausea—Cabazitaxel—prostate cancer	0.000606	0.00291	CcSEcCtD
Terbutaline—Salbutamol—ADRB2—prostate cancer	0.000605	0.0715	CrCbGaD
Terbutaline—Ventricular extrasystoles—Doxorubicin—prostate cancer	0.000602	0.00289	CcSEcCtD
Terbutaline—Tachycardia—Goserelin—prostate cancer	0.000594	0.00285	CcSEcCtD
Terbutaline—Hyperhidrosis—Goserelin—prostate cancer	0.000588	0.00283	CcSEcCtD
Terbutaline—Tachycardia—Conjugated Estrogens—prostate cancer	0.000588	0.00283	CcSEcCtD
Terbutaline—Hyperhidrosis—Conjugated Estrogens—prostate cancer	0.000583	0.0028	CcSEcCtD
Terbutaline—Tension—Estradiol—prostate cancer	0.00058	0.00279	CcSEcCtD
Terbutaline—Dizziness—Bicalutamide—prostate cancer	0.000579	0.00278	CcSEcCtD
Terbutaline—Nervousness—Estradiol—prostate cancer	0.000574	0.00276	CcSEcCtD
Terbutaline—Cramp muscle—Docetaxel—prostate cancer	0.000569	0.00274	CcSEcCtD
Terbutaline—Muscle spasms—Estradiol—prostate cancer	0.000568	0.00273	CcSEcCtD
Terbutaline—Clenbuterol—CYP1A1—prostate cancer	0.000558	0.0659	CrCbGaD
Terbutaline—Vomiting—Bicalutamide—prostate cancer	0.000556	0.00267	CcSEcCtD
Terbutaline—Tremor—Estradiol—prostate cancer	0.000554	0.00266	CcSEcCtD
Terbutaline—Rash—Bicalutamide—prostate cancer	0.000552	0.00265	CcSEcCtD
Terbutaline—Dermatitis—Bicalutamide—prostate cancer	0.000551	0.00265	CcSEcCtD
Terbutaline—Insomnia—Goserelin—prostate cancer	0.000551	0.00264	CcSEcCtD
Terbutaline—Headache—Bicalutamide—prostate cancer	0.000548	0.00263	CcSEcCtD
Terbutaline—Paraesthesia—Goserelin—prostate cancer	0.000547	0.00263	CcSEcCtD
Terbutaline—Insomnia—Conjugated Estrogens—prostate cancer	0.000545	0.00262	CcSEcCtD
Terbutaline—Dyspnoea—Goserelin—prostate cancer	0.000543	0.00261	CcSEcCtD
Terbutaline—Paraesthesia—Conjugated Estrogens—prostate cancer	0.000541	0.0026	CcSEcCtD
Terbutaline—Somnolence—Goserelin—prostate cancer	0.000541	0.0026	CcSEcCtD
Terbutaline—Dyspnoea—Conjugated Estrogens—prostate cancer	0.000538	0.00258	CcSEcCtD
Terbutaline—Somnolence—Conjugated Estrogens—prostate cancer	0.000536	0.00257	CcSEcCtD
Terbutaline—Asthenia—Ethinyl Estradiol—prostate cancer	0.000531	0.00255	CcSEcCtD
Terbutaline—Palpitations—Estradiol—prostate cancer	0.000523	0.00251	CcSEcCtD
Terbutaline—Nausea—Bicalutamide—prostate cancer	0.00052	0.0025	CcSEcCtD
Terbutaline—Hypertonia—Epirubicin—prostate cancer	0.000515	0.00247	CcSEcCtD
Terbutaline—Chest pain—Estradiol—prostate cancer	0.000503	0.00242	CcSEcCtD
Terbutaline—Anxiety—Estradiol—prostate cancer	0.000502	0.00241	CcSEcCtD
Terbutaline—Dry mouth—Estradiol—prostate cancer	0.000492	0.00236	CcSEcCtD
Terbutaline—Dizziness—Ethinyl Estradiol—prostate cancer	0.000489	0.00235	CcSEcCtD
Terbutaline—Flushing—Etoposide—prostate cancer	0.000489	0.00235	CcSEcCtD
Terbutaline—Hypertonia—Doxorubicin—prostate cancer	0.000477	0.00229	CcSEcCtD
Terbutaline—Tachycardia—Estradiol—prostate cancer	0.000471	0.00226	CcSEcCtD
Terbutaline—Vomiting—Ethinyl Estradiol—prostate cancer	0.00047	0.00226	CcSEcCtD
Terbutaline—Chest pain—Mitoxantrone—prostate cancer	0.000469	0.00225	CcSEcCtD
Terbutaline—Anxiety—Mitoxantrone—prostate cancer	0.000467	0.00224	CcSEcCtD
Terbutaline—Hyperhidrosis—Estradiol—prostate cancer	0.000467	0.00224	CcSEcCtD
Terbutaline—Rash—Ethinyl Estradiol—prostate cancer	0.000466	0.00224	CcSEcCtD
Terbutaline—Dermatitis—Ethinyl Estradiol—prostate cancer	0.000466	0.00224	CcSEcCtD
Terbutaline—Headache—Ethinyl Estradiol—prostate cancer	0.000463	0.00223	CcSEcCtD
Terbutaline—Muscle spasms—Etoposide—prostate cancer	0.000441	0.00212	CcSEcCtD
Terbutaline—Nausea—Ethinyl Estradiol—prostate cancer	0.000439	0.00211	CcSEcCtD
Terbutaline—Tachycardia—Mitoxantrone—prostate cancer	0.000439	0.00211	CcSEcCtD
Terbutaline—Asthenia—Goserelin—prostate cancer	0.000437	0.0021	CcSEcCtD
Terbutaline—Insomnia—Estradiol—prostate cancer	0.000436	0.0021	CcSEcCtD
Terbutaline—Hyperhidrosis—Mitoxantrone—prostate cancer	0.000435	0.00209	CcSEcCtD
Terbutaline—Paraesthesia—Estradiol—prostate cancer	0.000433	0.00208	CcSEcCtD
Terbutaline—Asthenia—Conjugated Estrogens—prostate cancer	0.000433	0.00208	CcSEcCtD
Terbutaline—Dyspnoea—Estradiol—prostate cancer	0.00043	0.00207	CcSEcCtD
Terbutaline—Somnolence—Estradiol—prostate cancer	0.000429	0.00206	CcSEcCtD
Terbutaline—Epinephrine—SLC22A1—prostate cancer	0.000428	0.0506	CrCbGaD
Terbutaline—Flushing—Docetaxel—prostate cancer	0.000406	0.00195	CcSEcCtD
Terbutaline—Paraesthesia—Mitoxantrone—prostate cancer	0.000404	0.00194	CcSEcCtD
Terbutaline—Dizziness—Goserelin—prostate cancer	0.000403	0.00193	CcSEcCtD
Terbutaline—Dyspnoea—Mitoxantrone—prostate cancer	0.000401	0.00193	CcSEcCtD
Terbutaline—Somnolence—Mitoxantrone—prostate cancer	0.0004	0.00192	CcSEcCtD
Terbutaline—Dizziness—Conjugated Estrogens—prostate cancer	0.000399	0.00191	CcSEcCtD
Terbutaline—Flushing—Capecitabine—prostate cancer	0.000393	0.00189	CcSEcCtD
Terbutaline—Chest pain—Etoposide—prostate cancer	0.00039	0.00187	CcSEcCtD
Terbutaline—Vomiting—Goserelin—prostate cancer	0.000387	0.00186	CcSEcCtD
Terbutaline—Rash—Goserelin—prostate cancer	0.000384	0.00184	CcSEcCtD
Terbutaline—Dermatitis—Goserelin—prostate cancer	0.000383	0.00184	CcSEcCtD
Terbutaline—Vomiting—Conjugated Estrogens—prostate cancer	0.000383	0.00184	CcSEcCtD
Terbutaline—Headache—Goserelin—prostate cancer	0.000381	0.00183	CcSEcCtD
Terbutaline—Rash—Conjugated Estrogens—prostate cancer	0.00038	0.00183	CcSEcCtD
Terbutaline—Dermatitis—Conjugated Estrogens—prostate cancer	0.00038	0.00182	CcSEcCtD
Terbutaline—Headache—Conjugated Estrogens—prostate cancer	0.000378	0.00181	CcSEcCtD
Terbutaline—Hallucination—Prednisone—prostate cancer	0.000375	0.0018	CcSEcCtD
Terbutaline—Muscle spasms—Docetaxel—prostate cancer	0.000366	0.00176	CcSEcCtD
Terbutaline—Tachycardia—Etoposide—prostate cancer	0.000365	0.00175	CcSEcCtD
Terbutaline—Nausea—Goserelin—prostate cancer	0.000362	0.00174	CcSEcCtD
Terbutaline—Hyperhidrosis—Etoposide—prostate cancer	0.000362	0.00174	CcSEcCtD
Terbutaline—Nausea—Conjugated Estrogens—prostate cancer	0.000358	0.00172	CcSEcCtD
Terbutaline—Muscle spasms—Capecitabine—prostate cancer	0.000355	0.0017	CcSEcCtD
Terbutaline—Flushing—Prednisone—prostate cancer	0.00035	0.00168	CcSEcCtD
Terbutaline—Asthenia—Estradiol—prostate cancer	0.000346	0.00166	CcSEcCtD
Terbutaline—Tremor—Capecitabine—prostate cancer	0.000345	0.00166	CcSEcCtD
Terbutaline—Palpitations—Docetaxel—prostate cancer	0.000337	0.00162	CcSEcCtD
Terbutaline—Paraesthesia—Etoposide—prostate cancer	0.000336	0.00161	CcSEcCtD
Terbutaline—Dyspnoea—Etoposide—prostate cancer	0.000333	0.0016	CcSEcCtD
Terbutaline—Somnolence—Etoposide—prostate cancer	0.000332	0.0016	CcSEcCtD
Terbutaline—Salbutamol—CYP3A4—prostate cancer	0.000331	0.0391	CrCbGaD
Terbutaline—Drowsiness—Epirubicin—prostate cancer	0.000329	0.00158	CcSEcCtD
Terbutaline—Palpitations—Capecitabine—prostate cancer	0.000326	0.00157	CcSEcCtD
Terbutaline—Isoprenaline—ADRB2—prostate cancer	0.000325	0.0384	CrCbGaD
Terbutaline—Chest pain—Docetaxel—prostate cancer	0.000324	0.00156	CcSEcCtD
Terbutaline—Asthenia—Mitoxantrone—prostate cancer	0.000323	0.00155	CcSEcCtD
Terbutaline—Dizziness—Estradiol—prostate cancer	0.000319	0.00153	CcSEcCtD
Terbutaline—Dry mouth—Docetaxel—prostate cancer	0.000317	0.00152	CcSEcCtD
Terbutaline—Sweating—Epirubicin—prostate cancer	0.000315	0.00151	CcSEcCtD
Terbutaline—Chest pain—Capecitabine—prostate cancer	0.000314	0.00151	CcSEcCtD
Terbutaline—Anxiety—Capecitabine—prostate cancer	0.000313	0.0015	CcSEcCtD
Terbutaline—Dry mouth—Capecitabine—prostate cancer	0.000307	0.00147	CcSEcCtD
Terbutaline—Vomiting—Estradiol—prostate cancer	0.000307	0.00147	CcSEcCtD
Terbutaline—Rash—Estradiol—prostate cancer	0.000304	0.00146	CcSEcCtD
Terbutaline—Drowsiness—Doxorubicin—prostate cancer	0.000304	0.00146	CcSEcCtD
Terbutaline—Dermatitis—Estradiol—prostate cancer	0.000304	0.00146	CcSEcCtD
Terbutaline—Tachycardia—Docetaxel—prostate cancer	0.000303	0.00146	CcSEcCtD
Terbutaline—Headache—Estradiol—prostate cancer	0.000302	0.00145	CcSEcCtD
Terbutaline—Tachycardia—Capecitabine—prostate cancer	0.000294	0.00141	CcSEcCtD
Terbutaline—Sweating—Doxorubicin—prostate cancer	0.000292	0.0014	CcSEcCtD
Terbutaline—Hyperhidrosis—Capecitabine—prostate cancer	0.000291	0.0014	CcSEcCtD
Terbutaline—Nausea—Estradiol—prostate cancer	0.000287	0.00138	CcSEcCtD
Terbutaline—Vomiting—Mitoxantrone—prostate cancer	0.000286	0.00137	CcSEcCtD
Terbutaline—Rash—Mitoxantrone—prostate cancer	0.000284	0.00136	CcSEcCtD
Terbutaline—Dermatitis—Mitoxantrone—prostate cancer	0.000283	0.00136	CcSEcCtD
Terbutaline—Headache—Mitoxantrone—prostate cancer	0.000282	0.00135	CcSEcCtD
Terbutaline—Insomnia—Docetaxel—prostate cancer	0.000281	0.00135	CcSEcCtD
Terbutaline—Paraesthesia—Docetaxel—prostate cancer	0.000279	0.00134	CcSEcCtD
Terbutaline—Isoprenaline—CYP1A1—prostate cancer	0.000279	0.033	CrCbGaD
Terbutaline—Anxiety—Prednisone—prostate cancer	0.000279	0.00134	CcSEcCtD
Terbutaline—Dyspnoea—Docetaxel—prostate cancer	0.000277	0.00133	CcSEcCtD
Terbutaline—Somnolence—Docetaxel—prostate cancer	0.000276	0.00133	CcSEcCtD
Terbutaline—Flushing—Epirubicin—prostate cancer	0.000274	0.00132	CcSEcCtD
Terbutaline—Epinephrine—ADRB2—prostate cancer	0.000273	0.0323	CrCbGaD
Terbutaline—Insomnia—Capecitabine—prostate cancer	0.000272	0.00131	CcSEcCtD
Terbutaline—Paraesthesia—Capecitabine—prostate cancer	0.00027	0.0013	CcSEcCtD
Terbutaline—Asthenia—Etoposide—prostate cancer	0.000268	0.00129	CcSEcCtD
Terbutaline—Dyspnoea—Capecitabine—prostate cancer	0.000268	0.00129	CcSEcCtD
Terbutaline—Nausea—Mitoxantrone—prostate cancer	0.000267	0.00128	CcSEcCtD
Terbutaline—Tachycardia—Prednisone—prostate cancer	0.000262	0.00126	CcSEcCtD
Terbutaline—Hyperhidrosis—Prednisone—prostate cancer	0.000259	0.00124	CcSEcCtD
Terbutaline—Flushing—Doxorubicin—prostate cancer	0.000253	0.00122	CcSEcCtD
Terbutaline—Tension—Epirubicin—prostate cancer	0.000252	0.00121	CcSEcCtD
Terbutaline—Nervousness—Epirubicin—prostate cancer	0.000249	0.0012	CcSEcCtD
Terbutaline—Dizziness—Etoposide—prostate cancer	0.000247	0.00119	CcSEcCtD
Terbutaline—Muscle spasms—Epirubicin—prostate cancer	0.000247	0.00119	CcSEcCtD
Terbutaline—Insomnia—Prednisone—prostate cancer	0.000242	0.00116	CcSEcCtD
Terbutaline—Paraesthesia—Prednisone—prostate cancer	0.000241	0.00116	CcSEcCtD
Terbutaline—Vomiting—Etoposide—prostate cancer	0.000238	0.00114	CcSEcCtD
Terbutaline—Rash—Etoposide—prostate cancer	0.000236	0.00113	CcSEcCtD
Terbutaline—Dermatitis—Etoposide—prostate cancer	0.000236	0.00113	CcSEcCtD
Terbutaline—Headache—Etoposide—prostate cancer	0.000234	0.00113	CcSEcCtD
Terbutaline—Tension—Doxorubicin—prostate cancer	0.000233	0.00112	CcSEcCtD
Terbutaline—Nervousness—Doxorubicin—prostate cancer	0.000231	0.00111	CcSEcCtD
Terbutaline—Muscle spasms—Doxorubicin—prostate cancer	0.000229	0.0011	CcSEcCtD
Terbutaline—Palpitations—Epirubicin—prostate cancer	0.000227	0.00109	CcSEcCtD
Terbutaline—Asthenia—Docetaxel—prostate cancer	0.000223	0.00107	CcSEcCtD
Terbutaline—Nausea—Etoposide—prostate cancer	0.000222	0.00107	CcSEcCtD
Terbutaline—Chest pain—Epirubicin—prostate cancer	0.000219	0.00105	CcSEcCtD
Terbutaline—Anxiety—Epirubicin—prostate cancer	0.000218	0.00105	CcSEcCtD
Terbutaline—Asthenia—Capecitabine—prostate cancer	0.000216	0.00104	CcSEcCtD
Terbutaline—Dry mouth—Epirubicin—prostate cancer	0.000214	0.00103	CcSEcCtD
Terbutaline—Palpitations—Doxorubicin—prostate cancer	0.00021	0.00101	CcSEcCtD
Terbutaline—Dizziness—Docetaxel—prostate cancer	0.000206	0.000987	CcSEcCtD
Terbutaline—Tachycardia—Epirubicin—prostate cancer	0.000205	0.000983	CcSEcCtD
Terbutaline—Hyperhidrosis—Epirubicin—prostate cancer	0.000203	0.000973	CcSEcCtD
Terbutaline—Chest pain—Doxorubicin—prostate cancer	0.000202	0.000972	CcSEcCtD
Terbutaline—Anxiety—Doxorubicin—prostate cancer	0.000202	0.000969	CcSEcCtD
Terbutaline—Dizziness—Capecitabine—prostate cancer	0.000199	0.000956	CcSEcCtD
Terbutaline—Dry mouth—Doxorubicin—prostate cancer	0.000198	0.00095	CcSEcCtD
Terbutaline—Vomiting—Docetaxel—prostate cancer	0.000198	0.000949	CcSEcCtD
Terbutaline—Rash—Docetaxel—prostate cancer	0.000196	0.000941	CcSEcCtD
Terbutaline—Dermatitis—Docetaxel—prostate cancer	0.000196	0.00094	CcSEcCtD
Terbutaline—Headache—Docetaxel—prostate cancer	0.000195	0.000935	CcSEcCtD
Terbutaline—Asthenia—Prednisone—prostate cancer	0.000192	0.000924	CcSEcCtD
Terbutaline—Vomiting—Capecitabine—prostate cancer	0.000191	0.000919	CcSEcCtD
Terbutaline—Rash—Capecitabine—prostate cancer	0.00019	0.000911	CcSEcCtD
Terbutaline—Insomnia—Epirubicin—prostate cancer	0.00019	0.000911	CcSEcCtD
Terbutaline—Dermatitis—Capecitabine—prostate cancer	0.00019	0.00091	CcSEcCtD
Terbutaline—Tachycardia—Doxorubicin—prostate cancer	0.000189	0.000909	CcSEcCtD
Terbutaline—Headache—Capecitabine—prostate cancer	0.000189	0.000905	CcSEcCtD
Terbutaline—Paraesthesia—Epirubicin—prostate cancer	0.000188	0.000904	CcSEcCtD
Terbutaline—Hyperhidrosis—Doxorubicin—prostate cancer	0.000188	0.000901	CcSEcCtD
Terbutaline—Dyspnoea—Epirubicin—prostate cancer	0.000187	0.000898	CcSEcCtD
Terbutaline—Somnolence—Epirubicin—prostate cancer	0.000186	0.000895	CcSEcCtD
Terbutaline—Nausea—Docetaxel—prostate cancer	0.000185	0.000887	CcSEcCtD
Terbutaline—Nausea—Capecitabine—prostate cancer	0.000179	0.000859	CcSEcCtD
Terbutaline—Dizziness—Prednisone—prostate cancer	0.000177	0.000851	CcSEcCtD
Terbutaline—Insomnia—Doxorubicin—prostate cancer	0.000175	0.000843	CcSEcCtD
Terbutaline—Paraesthesia—Doxorubicin—prostate cancer	0.000174	0.000837	CcSEcCtD
Terbutaline—Dyspnoea—Doxorubicin—prostate cancer	0.000173	0.000831	CcSEcCtD
Terbutaline—Somnolence—Doxorubicin—prostate cancer	0.000172	0.000828	CcSEcCtD
Terbutaline—Vomiting—Prednisone—prostate cancer	0.00017	0.000819	CcSEcCtD
Terbutaline—Rash—Prednisone—prostate cancer	0.000169	0.000812	CcSEcCtD
Terbutaline—Dermatitis—Prednisone—prostate cancer	0.000169	0.000811	CcSEcCtD
Terbutaline—Headache—Prednisone—prostate cancer	0.000168	0.000807	CcSEcCtD
Terbutaline—Nausea—Prednisone—prostate cancer	0.000159	0.000765	CcSEcCtD
Terbutaline—Asthenia—Epirubicin—prostate cancer	0.00015	0.000722	CcSEcCtD
Terbutaline—Epinephrine—CYP3A4—prostate cancer	0.00015	0.0177	CrCbGaD
Terbutaline—Asthenia—Doxorubicin—prostate cancer	0.000139	0.000668	CcSEcCtD
Terbutaline—Dizziness—Epirubicin—prostate cancer	0.000139	0.000666	CcSEcCtD
Terbutaline—Vomiting—Epirubicin—prostate cancer	0.000133	0.00064	CcSEcCtD
Terbutaline—Rash—Epirubicin—prostate cancer	0.000132	0.000635	CcSEcCtD
Terbutaline—Dermatitis—Epirubicin—prostate cancer	0.000132	0.000634	CcSEcCtD
Terbutaline—Headache—Epirubicin—prostate cancer	0.000131	0.000631	CcSEcCtD
Terbutaline—Dizziness—Doxorubicin—prostate cancer	0.000128	0.000616	CcSEcCtD
Terbutaline—Nausea—Epirubicin—prostate cancer	0.000125	0.000598	CcSEcCtD
Terbutaline—Vomiting—Doxorubicin—prostate cancer	0.000123	0.000592	CcSEcCtD
Terbutaline—Rash—Doxorubicin—prostate cancer	0.000122	0.000587	CcSEcCtD
Terbutaline—Dermatitis—Doxorubicin—prostate cancer	0.000122	0.000587	CcSEcCtD
Terbutaline—Headache—Doxorubicin—prostate cancer	0.000122	0.000584	CcSEcCtD
Terbutaline—Nausea—Doxorubicin—prostate cancer	0.000115	0.000553	CcSEcCtD
Terbutaline—ADRB2—Signaling Pathways—RLN2—prostate cancer	5.54e-05	0.00119	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	5.48e-05	0.00118	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—LPAR1—prostate cancer	5.48e-05	0.00118	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—GRP—prostate cancer	5.48e-05	0.00118	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—SULT1E1—prostate cancer	5.46e-05	0.00118	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—SRD5A1—prostate cancer	5.46e-05	0.00118	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—PLCB2—prostate cancer	5.42e-05	0.00117	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	5.31e-05	0.00114	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CTBP2—prostate cancer	5.28e-05	0.00114	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—HSD17B1—prostate cancer	5.28e-05	0.00114	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—CALR—prostate cancer	5.27e-05	0.00113	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	5.23e-05	0.00113	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—HSD17B3—prostate cancer	5.21e-05	0.00112	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—ACSL4—prostate cancer	5.21e-05	0.00112	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—PDE4D—prostate cancer	5.17e-05	0.00111	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	5.15e-05	0.00111	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—GNRH1—prostate cancer	5.13e-05	0.00111	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—VIP—prostate cancer	5.13e-05	0.00111	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PLXNB1—prostate cancer	5.06e-05	0.00109	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—ACE—prostate cancer	5.01e-05	0.00108	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—UMPS—prostate cancer	5e-05	0.00108	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PHGDH—prostate cancer	5e-05	0.00108	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—ARG2—prostate cancer	5e-05	0.00108	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	4.97e-05	0.00107	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—LPAR1—prostate cancer	4.97e-05	0.00107	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—GRP—prostate cancer	4.97e-05	0.00107	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—PLCB2—prostate cancer	4.92e-05	0.00106	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—GNG5—prostate cancer	4.92e-05	0.00106	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—LDHB—prostate cancer	4.9e-05	0.00105	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—GRPR—prostate cancer	4.87e-05	0.00105	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—CX3CL1—prostate cancer	4.83e-05	0.00104	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—CYP3A5—prostate cancer	4.81e-05	0.00104	CbGpPWpGaD
Terbutaline—BCHE—Phospholipid metabolism—PIK3CA—prostate cancer	4.72e-05	0.00102	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—IL17RD—prostate cancer	4.71e-05	0.00101	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—PDE4D—prostate cancer	4.7e-05	0.00101	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PDHA1—prostate cancer	4.65e-05	0.001	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—UCP3—prostate cancer	4.65e-05	0.001	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—GSTA3—prostate cancer	4.65e-05	0.001	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—TCN2—prostate cancer	4.65e-05	0.001	CbGpPWpGaD
Terbutaline—BCHE—Neuronal System—MDM2—prostate cancer	4.53e-05	0.000975	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—PLAUR—prostate cancer	4.5e-05	0.00097	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—GNG5—prostate cancer	4.47e-05	0.000961	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—HSD3B1—prostate cancer	4.43e-05	0.000954	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—SLC22A3—prostate cancer	4.43e-05	0.000954	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—LPL—prostate cancer	4.3e-05	0.000926	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—PTHLH—prostate cancer	4.29e-05	0.000922	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—TBXAS1—prostate cancer	4.25e-05	0.000915	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—GSTA4—prostate cancer	4.25e-05	0.000915	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—JUP—prostate cancer	4.2e-05	0.000903	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—WNT4—prostate cancer	4.2e-05	0.000903	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	4.15e-05	0.000894	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—GSTA2—prostate cancer	4.14e-05	0.000891	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—ABCG5—prostate cancer	4.09e-05	0.00088	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—SULT1A1—prostate cancer	4.09e-05	0.00088	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—ANXA1—prostate cancer	4.03e-05	0.000867	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—MC2R—prostate cancer	4e-05	0.000861	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—RALBP1—prostate cancer	4e-05	0.000861	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—GSTA1—prostate cancer	4e-05	0.00086	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—HSD3B2—prostate cancer	3.95e-05	0.00085	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—GSTO1—prostate cancer	3.95e-05	0.00085	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—NAT2—prostate cancer	3.95e-05	0.00085	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—PTHLH—prostate cancer	3.89e-05	0.000838	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—PRKACB—prostate cancer	3.81e-05	0.00082	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	3.8e-05	0.000818	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—CYP2C18—prostate cancer	3.79e-05	0.000815	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PLCB2—prostate cancer	3.79e-05	0.000815	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—LRP2—prostate cancer	3.79e-05	0.000815	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—CALCA—prostate cancer	3.77e-05	0.000812	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—P4HB—prostate cancer	3.71e-05	0.0008	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—PPP3CA—prostate cancer	3.71e-05	0.000799	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—CXCL12—prostate cancer	3.68e-05	0.000793	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—ANXA1—prostate cancer	3.66e-05	0.000787	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—SLC22A1—prostate cancer	3.61e-05	0.000778	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	3.57e-05	0.000769	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PENK—prostate cancer	3.57e-05	0.000768	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—prostate cancer	3.55e-05	0.000764	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—SULT2A1—prostate cancer	3.52e-05	0.000758	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—MED12—prostate cancer	3.46e-05	0.000746	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—GNG5—prostate cancer	3.44e-05	0.00074	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—CALCA—prostate cancer	3.43e-05	0.000737	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—GHR—prostate cancer	3.4e-05	0.000732	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—PRKCQ—prostate cancer	3.36e-05	0.000724	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—CXCL12—prostate cancer	3.35e-05	0.00072	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—NCOA3—prostate cancer	3.31e-05	0.000713	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—NRP1—prostate cancer	3.26e-05	0.000702	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	3.25e-05	0.0007	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—HPGDS—prostate cancer	3.16e-05	0.00068	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—CYP2C19—prostate cancer	3.14e-05	0.000676	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—LEP—prostate cancer	3.12e-05	0.00067	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—VAV3—prostate cancer	3.08e-05	0.000664	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—ACHE—prostate cancer	3.06e-05	0.000659	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—GSTT1—prostate cancer	3.06e-05	0.000659	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—PRKCQ—prostate cancer	3.05e-05	0.000657	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—GNRH1—prostate cancer	3.03e-05	0.000653	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—VIP—prostate cancer	3.03e-05	0.000653	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—CYP2A6—prostate cancer	3.03e-05	0.000652	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	3.02e-05	0.000649	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—ITPR1—prostate cancer	2.99e-05	0.000644	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—AKR1C3—prostate cancer	2.95e-05	0.000634	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—LPAR1—prostate cancer	2.94e-05	0.000632	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—GRP—prostate cancer	2.94e-05	0.000632	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PRKACB—prostate cancer	2.93e-05	0.000631	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PLCB2—prostate cancer	2.91e-05	0.000626	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—LRP2—prostate cancer	2.91e-05	0.000626	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—CYP17A1—prostate cancer	2.9e-05	0.000624	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	2.86e-05	0.000616	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—P4HB—prostate cancer	2.85e-05	0.000614	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CX3CL1—prostate cancer	2.85e-05	0.000614	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—VAV3—prostate cancer	2.8e-05	0.000603	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—HIST1H2BG—prostate cancer	2.8e-05	0.000602	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PDE4D—prostate cancer	2.77e-05	0.000597	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—GRB7—prostate cancer	2.77e-05	0.000597	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—NCOA2—prostate cancer	2.76e-05	0.000595	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—ITPR1—prostate cancer	2.72e-05	0.000584	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—HIST1H4H—prostate cancer	2.7e-05	0.000582	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—CXCL8—prostate cancer	2.7e-05	0.000582	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—INS—prostate cancer	2.66e-05	0.000573	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—GNG5—prostate cancer	2.64e-05	0.000568	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—SLC5A5—prostate cancer	2.64e-05	0.000567	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—CYP2E1—prostate cancer	2.57e-05	0.000554	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—IGF1—prostate cancer	2.57e-05	0.000554	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—NQO1—prostate cancer	2.55e-05	0.000548	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—TH—prostate cancer	2.51e-05	0.00054	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	2.49e-05	0.000537	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—MMP2—prostate cancer	2.49e-05	0.000536	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—CYP3A4—prostate cancer	2.48e-05	0.000534	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	2.47e-05	0.000532	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—CYP1B1—prostate cancer	2.44e-05	0.000525	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—GGT1—prostate cancer	2.36e-05	0.000509	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—NCOA1—prostate cancer	2.33e-05	0.000501	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PTHLH—prostate cancer	2.3e-05	0.000495	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—TGFBR1—prostate cancer	2.3e-05	0.000495	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—CYP19A1—prostate cancer	2.29e-05	0.000494	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—AKR1C3—prostate cancer	2.26e-05	0.000487	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PRKACB—prostate cancer	2.25e-05	0.000484	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—RXRA—prostate cancer	2.21e-05	0.000477	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PPP3CA—prostate cancer	2.19e-05	0.000472	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—THBS1—prostate cancer	2.19e-05	0.000472	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—ANXA1—prostate cancer	2.16e-05	0.000465	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.15e-05	0.000464	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—COMT—prostate cancer	2.13e-05	0.000459	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—GSTP1—prostate cancer	2.12e-05	0.000457	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PRKCZ—prostate cancer	2.12e-05	0.000457	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—ITPR1—prostate cancer	2.09e-05	0.00045	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—PIK3CG—prostate cancer	2.07e-05	0.000446	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—CXCL8—prostate cancer	2.07e-05	0.000446	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.05e-05	0.000442	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—FGFR4—prostate cancer	2.05e-05	0.000441	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PARP1—prostate cancer	2.05e-05	0.000441	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CALCA—prostate cancer	2.02e-05	0.000436	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CXCL12—prostate cancer	1.98e-05	0.000425	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—TYMS—prostate cancer	1.97e-05	0.000425	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—GSTM1—prostate cancer	1.95e-05	0.00042	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—LPL—prostate cancer	1.92e-05	0.000412	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—CTNNB1—prostate cancer	1.91e-05	0.000411	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—PIK3CG—prostate cancer	1.88e-05	0.000405	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CASP9—prostate cancer	1.86e-05	0.000401	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—CYP1A1—prostate cancer	1.85e-05	0.000398	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—ERCC2—prostate cancer	1.83e-05	0.000395	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—PIK3CD—prostate cancer	1.82e-05	0.000392	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—NGFR—prostate cancer	1.8e-05	0.000388	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PRKCQ—prostate cancer	1.8e-05	0.000388	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—MAP3K7—prostate cancer	1.78e-05	0.000384	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—MTHFR—prostate cancer	1.72e-05	0.000371	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—FGF10—prostate cancer	1.71e-05	0.000369	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PPARA—prostate cancer	1.69e-05	0.000364	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—JAK2—prostate cancer	1.67e-05	0.00036	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—MAP2K1—prostate cancer	1.67e-05	0.000359	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—PIK3CD—prostate cancer	1.66e-05	0.000356	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—VAV3—prostate cancer	1.65e-05	0.000356	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—TGFBR2—prostate cancer	1.63e-05	0.000351	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—ITPR1—prostate cancer	1.6e-05	0.000345	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—CAV1—prostate cancer	1.59e-05	0.000342	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—PIK3CB—prostate cancer	1.59e-05	0.000342	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—IGF1R—prostate cancer	1.53e-05	0.00033	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—CXCL8—prostate cancer	1.53e-05	0.000329	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.52e-05	0.000327	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—JAK2—prostate cancer	1.52e-05	0.000327	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—LPL—prostate cancer	1.47e-05	0.000316	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—IL2—prostate cancer	1.46e-05	0.000314	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PDGFRB—prostate cancer	1.46e-05	0.000314	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PIK3CG—prostate cancer	1.45e-05	0.000312	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—PIK3CB—prostate cancer	1.44e-05	0.000311	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—ITGB3—prostate cancer	1.42e-05	0.000306	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—CXCL8—prostate cancer	1.39e-05	0.000298	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—ERBB3—prostate cancer	1.38e-05	0.000296	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—FGFR2—prostate cancer	1.38e-05	0.000296	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—INS—prostate cancer	1.37e-05	0.000295	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—CREBBP—prostate cancer	1.34e-05	0.000289	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—IL2—prostate cancer	1.33e-05	0.000285	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—TERT—prostate cancer	1.32e-05	0.000284	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PIK3CD—prostate cancer	1.27e-05	0.000274	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—HIF1A—prostate cancer	1.26e-05	0.000272	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—LEP—prostate cancer	1.23e-05	0.000265	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CAV1—prostate cancer	1.22e-05	0.000263	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—KDR—prostate cancer	1.21e-05	0.00026	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—NOS3—prostate cancer	1.2e-05	0.000259	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—ESR1—prostate cancer	1.18e-05	0.000253	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—BAD—prostate cancer	1.15e-05	0.000247	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PIK3CG—prostate cancer	1.11e-05	0.000239	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—APC—prostate cancer	1.11e-05	0.000239	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PIK3CB—prostate cancer	1.11e-05	0.000239	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PTGS2—prostate cancer	1.1e-05	0.000237	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—EGF—prostate cancer	1.1e-05	0.000237	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—IRS1—prostate cancer	1.1e-05	0.000237	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—GSK3B—prostate cancer	1.07e-05	0.00023	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—INS—prostate cancer	1.05e-05	0.000227	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CREBBP—prostate cancer	1.03e-05	0.000222	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—IGF1—prostate cancer	1.02e-05	0.000219	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—EGFR—prostate cancer	1.01e-05	0.000218	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—MAP2K1—prostate cancer	9.84e-06	0.000212	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PIK3CD—prostate cancer	9.78e-06	0.00021	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—PIK3CA—prostate cancer	9.69e-06	0.000208	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—SERPINE1—prostate cancer	9.67e-06	0.000208	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PTEN—prostate cancer	9.59e-06	0.000206	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—KRAS—prostate cancer	9.57e-06	0.000206	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—FGF2—prostate cancer	9.36e-06	0.000202	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—NOS3—prostate cancer	9.23e-06	0.000199	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—EP300—prostate cancer	9.15e-06	0.000197	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—JAK2—prostate cancer	8.97e-06	0.000193	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—PIK3CA—prostate cancer	8.8e-06	0.000189	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—MDM2—prostate cancer	8.76e-06	0.000189	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—ERBB2—prostate cancer	8.64e-06	0.000186	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PIK3CB—prostate cancer	8.52e-06	0.000183	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CXCL8—prostate cancer	8.19e-06	0.000176	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CDKN1B—prostate cancer	8e-06	0.000172	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—AKT1—prostate cancer	7.91e-06	0.00017	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CASP3—prostate cancer	7.84e-06	0.000169	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—IL2—prostate cancer	7.83e-06	0.000168	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—IL6—prostate cancer	7.79e-06	0.000168	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CCND1—prostate cancer	7.63e-06	0.000164	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CTNNB1—prostate cancer	7.56e-06	0.000163	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—MMP9—prostate cancer	7.41e-06	0.000159	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CDKN1A—prostate cancer	7.38e-06	0.000159	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PTEN—prostate cancer	7.37e-06	0.000159	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—AKT1—prostate cancer	7.19e-06	0.000155	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—EP300—prostate cancer	7.02e-06	0.000151	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—SRC—prostate cancer	6.83e-06	0.000147	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PIK3CA—prostate cancer	6.77e-06	0.000146	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—VEGFA—prostate cancer	6.65e-06	0.000143	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—STAT3—prostate cancer	6.59e-06	0.000142	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—MYC—prostate cancer	6.12e-06	0.000132	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—TGFB1—prostate cancer	6.11e-06	0.000131	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—EGFR—prostate cancer	5.99e-06	0.000129	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—KRAS—prostate cancer	5.66e-06	0.000122	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—AKT1—prostate cancer	5.53e-06	0.000119	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PIK3CA—prostate cancer	5.2e-06	0.000112	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—TP53—prostate cancer	5.03e-06	0.000108	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—IL6—prostate cancer	4.6e-06	9.9e-05	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—AKT1—prostate cancer	4.24e-06	9.14e-05	CbGpPWpGaD
